GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,389.00p
   
  • Change Today:
    -5.00p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,113.33m
  • Volume: 7,504,355
  • Market Cap: £57,134m
  • RiskGrade: 129

Latest ShareCast News

Two GSK vaccines get US CDC recommendations

By Josh White

Date: Thursday 17 Apr 2025

(Sharecast News) - GSK announced two important endorsements from the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) on Thursday, for its vaccines Penmenvy and Arexvy, potentially expanding protection against meningococcal disease and respiratory syncytial virus (RSV) for millions of Americans.

GSK ShareCast News

London close: Stocks fall as China retaliates to... 09-Apr-2025 ShareCast
London close: Stocks slide in global reaction to... 03-Apr-2025 ShareCast
UK pharma stocks avoid selloff 03-Apr-2025 ShareCast
EMA accepts GSK's application to expand Nucala use 24-Mar-2025 ShareCast
FDA to review GSK's depemokimab 03-Mar-2025 ShareCast

GSK Regulatory News

Transaction in Own Shares 25-Apr-2025 07:00 RNS
Transaction in Own Shares 24-Apr-2025 07:00 RNS
Transaction in Own Shares 23-Apr-2025 07:00 RNS
Transaction in Own Shares 22-Apr-2025 07:00 RNS
Blenrep licensed by UK MHRA 17-Apr-2025 16:13 RNS

GSK Newspaper Links

GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph
GlaxoSmithKline tops table in effort to get drug... 17-Nov-2014 Guardian

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,389.00p
Change Today -5.00p
% Change -0.36 %
52 Week High 1,812.50p
52 Week Low 1,264.00p
Volume 7,504,355
Shares Issued 4,113.33m
Market Cap £57,134m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.15% below the market average39.15% below the market average39.15% below the market average39.15% below the market average39.15% below the market average
44.68% above the sector average44.68% above the sector average44.68% above the sector average44.68% above the sector average44.68% above the sector average
Price Trend
12.83% below the market average12.83% below the market average12.83% below the market average12.83% below the market average12.83% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income
71.62% above the market average71.62% above the market average71.62% above the market average71.62% above the market average71.62% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
44.04% below the market average44.04% below the market average44.04% below the market average44.04% below the market average44.04% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 20-Feb-25 14-Nov-24
Paid 10-Apr-25 09-Jan-25
Amount 16.00p 15.00p

Trades for 25-Apr-2025

Time Volume / Share Price
16:25 0 @ 1,390.00p
16:38 2,580 @ 1,389.00p
16:38 2,580 @ 1,389.00p
15:43 67 @ 1,388.00p
16:36 20 @ 1,389.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page